These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
253 related articles for article (PubMed ID: 11077233)
1. Menopause and depression: a review of psychologic function and sex steroid neurobiology during the menopause(1). Richardson TA; Robinson RD Prim Care Update Ob Gyns; 2000 Nov; 7(6):215-223. PubMed ID: 11077233 [TBL] [Abstract][Full Text] [Related]
2. The effects of compounded bioidentical transdermal hormone therapy on hemostatic, inflammatory, immune factors; cardiovascular biomarkers; quality-of-life measures; and health outcomes in perimenopausal and postmenopausal women. Stephenson K; Neuenschwander PF; Kurdowska AK Int J Pharm Compd; 2013; 17(1):74-85. PubMed ID: 23627249 [TBL] [Abstract][Full Text] [Related]
3. Effect of reproductive hormones and selective estrogen receptor modulators on mood during menopause. Soares CN; Poitras JR; Prouty J Drugs Aging; 2003; 20(2):85-100. PubMed ID: 12534310 [TBL] [Abstract][Full Text] [Related]
4. DHEA, important source of sex steroids in men and even more in women. Labrie F Prog Brain Res; 2010; 182():97-148. PubMed ID: 20541662 [TBL] [Abstract][Full Text] [Related]
5. Prognostic features of menopausal and postmenopausal applicants for life insurance. Schiefeling M J Insur Med; 1996; 28(1):27-34. PubMed ID: 10172866 [TBL] [Abstract][Full Text] [Related]
6. Mood disorders and menopause. Pearlstein T; Rosen K; Stone AB Endocrinol Metab Clin North Am; 1997 Jun; 26(2):279-94. PubMed ID: 9193884 [TBL] [Abstract][Full Text] [Related]
7. Prevalence of hormone replacement therapy and antidepressant use in peri- and postmenopausal women. Gartrell NK; Koh AS; Becker C; LaVoy A; Rosen S; Thiemann S J Gend Specif Med; 2001; 4(1):60-3. PubMed ID: 11324242 [TBL] [Abstract][Full Text] [Related]
8. Steroids, reproductive endocrine function, and affect. A review. Frye CA Minerva Ginecol; 2009 Dec; 61(6):541-62. PubMed ID: 19942840 [TBL] [Abstract][Full Text] [Related]
16. Efficacy of citalopram as a monotherapy or as an adjunctive treatment to estrogen therapy for perimenopausal and postmenopausal women with depression and vasomotor symptoms. Soares CN; Poitras JR; Prouty J; Alexander AB; Shifren JL; Cohen LS J Clin Psychiatry; 2003 Apr; 64(4):473-9. PubMed ID: 12716252 [TBL] [Abstract][Full Text] [Related]
17. Depression and the menopause: why antidepressants are not enough? Graziottin A; Serafini A Menopause Int; 2009 Jun; 15(2):76-81. PubMed ID: 19465674 [TBL] [Abstract][Full Text] [Related]
18. Efficacy of Transdermal Estradiol and Micronized Progesterone in the Prevention of Depressive Symptoms in the Menopause Transition: A Randomized Clinical Trial. Gordon JL; Rubinow DR; Eisenlohr-Moul TA; Xia K; Schmidt PJ; Girdler SS JAMA Psychiatry; 2018 Feb; 75(2):149-157. PubMed ID: 29322164 [TBL] [Abstract][Full Text] [Related]
19. Estrogen use and depressive symptoms in postmenopausal women. Palinkas LA; Barrett-Connor E Obstet Gynecol; 1992 Jul; 80(1):30-6. PubMed ID: 1603493 [TBL] [Abstract][Full Text] [Related]
20. Do estradiol levels influence on the cognitive function during antidepressant treatments in post-menopausal women with major depressive disorder? A comparison with pre-menopausal women. Pae CU; Mandelli L; Han C; Ham BJ; Masand PS; Patkar AA; Steffens DC; De Ronchi D; Serretti A Neuro Endocrinol Lett; 2008 Aug; 29(4):500-6. PubMed ID: 18766158 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]